- Home
- BIOA vs SXTC Comparison
BIOA vs SXTC Comparison
Compare BIOA & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIOA | SXTC |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 184.5M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BIOA | SXTC |
|---|---|---|
| Price | $11.37 | $1.43 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 283.2K | 273.2K |
| Earning Date | 11-06-2025 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,917,000.00 | $1,740,907.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.88 | $0.95 |
| 52 Week High | $20.37 | $7.84 |
Technical Indicators
Market Signals| Indicator | BIOA | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 78.27 | 51.44 |
| Support Level | $8.46 | $1.40 |
| Resistance Level | $9.62 | $1.52 |
| Average True Range (ATR) | 0.58 | 0.10 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 97.30 | 37.14 |
Price Performance
Historical ComparisonAbout BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.